Teva Stock Falls After Earnings and Revenue Miss Estimates | Barron's
Teva Pharmaceutical Industries Ltd. Meets Earnings Targets Despite a Mild European Winter | The Motley Fool
Here's Why Teva Shares are Trending Higher Today
Teva Pharmaceutical Industries Third Quarter 2022 Earnings: Misses Expectations
Teva gains on earnings beat
Teva earnings preview: Opioid suits are 'key' - MarketWatch
Teva soars after earnings beat, increased guidance - TheStreet
Earnings season continues: BMS revenue inches up, Teva lowers outlook
Teva Pharmaceutical falls 6% on eve of Q3 earnings show | Seeking Alpha
Teva Pharmaceutical: Earnings Trends and Recent Developments
Teva Shares Spike After Q1 Earnings Beat, Full Year Forecast Boost - TheStreet
Teva reports jump in first-quarter earnings, raises guidance | The Times of Israel
Teva Reports Fourth Quarter and Full Year 2019 Financial Results | Business Wire
Teva Pharmaceutical beats Q4 earnings, sales estimates - Drug Delivery Business
TEVA Gears Up to Report Q3 Earnings: What's in the Cards?
Teva taps new CFO, hikes legal set-aside to more than $1B as opioid deal falters | Fierce Pharma
Q3 pharma earnings roundup: Moderna, Regeneron and Teva
Teva Pharmaceutical revenue 2006-2021 | Statista
Teva Pharmaceutical Industries Limited 2018 Q2 - Results - Earnings Call Slides (NYSE:TEVA) | Seeking Alpha
Teva Pharmaceutical Industries Third Quarter 2022 Earnings: Misses Expectations - Simply Wall St News
Teva earnings Q2 2018 | AlphaStreet
Teva Pharmaceutical earnings per share 2006-2021 | Statista
Teva Q2 Earnings: 5 Reasons Why Shares Rose By 30% (NYSE:TEVA) | Seeking Alpha
Teva earnings: Facing down cheaper generic prices, generic competition of its own and a lot of debt - MarketWatch
Teva Pharmaceuticals on Twitter: "Our live Q2 2022 earnings call is starting soon! Join President & CEO Kåre Schultz to discuss Teva's business performance and plans ahead. Join here: https://t.co/VR9FyBqEz2 #QuarterlyResults #Earnings $
